173 related articles for article (PubMed ID: 34337900)
1. Temporal regulation of protein O-GlcNAc levels during pressure-overload cardiac hypertrophy.
Zhu WZ; Ledee D; Olson AK
Physiol Rep; 2021 Aug; 9(15):e14965. PubMed ID: 34337900
[TBL] [Abstract][Full Text] [Related]
2. First comprehensive identification of cardiac proteins with putative increased O-GlcNAc levels during pressure overload hypertrophy.
Zhu WZ; Palazzo T; Zhou M; Ledee D; Olson HM; Paša-Tolić L; Olson AK
PLoS One; 2022; 17(10):e0276285. PubMed ID: 36288343
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O-GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload.
Zhu WZ; El-Nachef D; Yang X; Ledee D; Olson AK
J Am Heart Assoc; 2019 Jun; 8(11):e011260. PubMed ID: 31131693
[TBL] [Abstract][Full Text] [Related]
4. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
5. c-Myc Alters Substrate Utilization and O-GlcNAc Protein Posttranslational Modifications without Altering Cardiac Function during Early Aortic Constriction.
Ledee D; Smith L; Bruce M; Kajimoto M; Isern N; Portman MA; Olson AK
PLoS One; 2015; 10(8):e0135262. PubMed ID: 26266538
[TBL] [Abstract][Full Text] [Related]
6. Cardiac hypertrophy drives PGC-1α suppression associated with enhanced O-glycosylation.
Brainard RE; Facundo HT
Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166080. PubMed ID: 33486096
[TBL] [Abstract][Full Text] [Related]
7.
Matsuno M; Yokoe S; Nagatsuka T; Morihara H; Moriwaki K; Asahi M
Front Endocrinol (Lausanne); 2023; 14():1122125. PubMed ID: 37033243
[No Abstract] [Full Text] [Related]
8. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
9. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
[TBL] [Abstract][Full Text] [Related]
10. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
11. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
Marsh SA; Dell'Italia LJ; Chatham JC
Amino Acids; 2011 Mar; 40(3):819-28. PubMed ID: 20676904
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.
Facundo HT; Brainard RE; Watson LJ; Ngoh GA; Hamid T; Prabhu SD; Jones SP
Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2122-30. PubMed ID: 22408028
[TBL] [Abstract][Full Text] [Related]
13. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
Belke DD
J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
[TBL] [Abstract][Full Text] [Related]
14. Immediate effects of a single exercise bout on protein O-GlcNAcylation and chromatin regulation of cardiac hypertrophy.
Medford HM; Porter K; Marsh SA
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H114-23. PubMed ID: 23624624
[TBL] [Abstract][Full Text] [Related]
15. GFAT2 mediates cardiac hypertrophy through HBP-O-GlcNAcylation-Akt pathway.
Ishikita A; Matsushima S; Ikeda S; Okabe K; Nishimura R; Tadokoro T; Enzan N; Yamamoto T; Sada M; Tsutsui Y; Miyake R; Ikeda M; Ide T; Kinugawa S; Tsutsui H
iScience; 2021 Dec; 24(12):103517. PubMed ID: 34934932
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
[TBL] [Abstract][Full Text] [Related]
17. Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.
Laczy B; Fülöp N; Onay-Besikci A; Des Rosiers C; Chatham JC
PLoS One; 2011 Apr; 6(4):e18417. PubMed ID: 21494549
[TBL] [Abstract][Full Text] [Related]
18. The Hexosamine Biosynthesis Pathway: Regulation and Function.
Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
[TBL] [Abstract][Full Text] [Related]
19. The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo.
Andrés-Bergós J; Tardio L; Larranaga-Vera A; Gómez R; Herrero-Beaumont G; Largo R
J Biol Chem; 2012 Sep; 287(40):33615-28. PubMed ID: 22859309
[TBL] [Abstract][Full Text] [Related]
20. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
